← Back to Patent Explorer
US4093721A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof

Assignee: Glaxo Laboratories Ltd
•
Filing: 1977-01-06
•
Granted: 1978-06-06
•
Expires: 1997-01-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The specification describes anti-inflammatory steroids having the following formula ##STR1## wherein X represents a hydrogen or fluorine atom, R' represents a methyl, ethyl, n-propyl or iso-propyl group, R" represents a methyl, chloromethyl, fluoromethyl, bromomethyl or 2-fluoroethyl group and represents a single or double bond. The specification describes processes for preparing such compounds as well as pharmaceutical compositions containing the compounds.

Inventors

  • 👤 Gordon H. Phillipps
  • 👤 Brian M. Bain

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 12:00
CPC Classifications
C; C07; C07J; C07J3/00; C07J3/005

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 41 words
Compounds of the general formula ##STR5## wherein X represents a hydrogen or fluorine atom, R' represents a methyl, ethyl, n-propyl or iso-propyl group, R" represents a methyl, chloromethyl, fluoromethyl, bromomethyl or 2- fluoroethyl group and represents a single or double bond.
Claim 2
Dependent Claim 41 words
Compounds of the general formula ##STR5## wherein X represents a hydrogen or fluorine atom, R' represents a methyl, ethyl, n-propyl or iso-propyl group, R" represents a methyl, chloromethyl, fluoromethyl, bromomethyl or 2- fluoroethyl group and represents a single or double bond.
Claim 3
Dependent Claim 12 words
Compounds as claimed in claim 1 wherein R' represents an ethyl group.
Claim 4
Dependent Claim 15 words
Compounds as claimed in claim 1 wherein R" represents a methyl, chloromethyl or fluoromethyl group.
Claim 5
Dependent Claim 13 words
A compound as claimed in claim 1, said compound being methyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17.alpha.-propionyloxy androsta-1,4diene-17β-carboxylate.
Claim 6
Dependent Claim 12 words
A compound as claimed in claim 1, said compound being fluoromethyl 6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxo-17.alpha.-propionyloxyandrost-4-ene-17β-carboxylate.
Claim 7
Dependent Claim 16 words
A compound as claimed in claim 1 selected from chloromethyl 6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxo-17.alpha.-propionyloxyandrost-4-ene-17β-carboxylate; methyl 6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxo-17.alpha.-propionyloxy-androsta-1,4-diene-17β-carboxylate; and methyl 6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxo-17.alpha.-propionyloxy-androst-4-ene-17β-carboxylate.
Claim 8
Dependent Claim 22 words
Pharmaceutical compositions comprising, as active ingredient, at least one compound of claim 1 together with at least one pharmaceutical carrier or excipient.
Claim 9
Dependent Claim 12 words
Compounds as claimed in claim 3 wherein X is a fluorine atom.
Claim 10
Dependent Claim 11 words
A compound as claimed in claim 1 which is methyl 6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxo-17.alpha.-propionyloxyandrost-4-ene-17β-carboxylate.
Claim 11
Dependent Claim 38 words
A composition as claimed in claim 7 adapted for topical administration comprising at least one topical carrier or excipient, wherein the compound is present in an amount in the range of from 0.0001 to 5.0 percent by weight.
Claim 12
Dependent Claim 14 words
The compound of claim 3 wherein the 16-methyl group is in the alpha configuration.
Claim 13
Dependent Claim 11 words
A compound as claimed in claim 1 which is chloromethyl 6α,9α-difluoro-11β-hydroxy-16β-methyl-3-oxo-17.alpha.-propionyloxyandrost-4-ene-17β-carboxylate.
Claim 14
Dependent Claim 20 words
A method of treating inflammation which comprises topically applying to the skin a composition as set forth in claim 10.

References Cited (Backward Citations)

US3636010A Cited
US3856828A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-06-05 1981-12-05 1982-06-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-06-05 1985-12-05 1986-06-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-06-05 1989-12-05 1990-06-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag